Expression of matrix metalloproteinases and their inhibitors by rat NK cells: Inhibition of their expression by genistein

In Vivo

Volumn 14, Issue 5, 2000, Pages 557-564

  Kim, Myoung H ^a   Albertsson, Per ^a   Xue, Yaming ^a   Kitson, Richard P ^a   Nannmark, Ulf ^a   Goldfarb, Ronald H ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Genistein; Interleukin 2 activated Natural Killer (A NK) cells; Matrix metalloproteinase (MMP); Tissue inhibitor of MMP (TIMP)

Indexed keywords

COLLAGENASE 3; COMPLEMENTARY DNA; GELATINASE A; GELATINASE B; GENISTEIN; ISOFLAVONE; MATRILYSIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MEMBRANE TYPE 2 MATRIX METALLOPROTEINASE; MESSENGER RNA; STROMELYSIN; STROMELYSIN 2; STROMELYSIN 3; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL INVASION; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG EFFECT; DRUG INHIBITION; LEUKEMIA CELL LINE; MALE; MOLECULAR WEIGHT; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 0034579433     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Natural killer cells and gene therapy: Potential of gene transfection for optimizing effector cell functions and for targeting gene products into tumor metastases
2. Antimetastatic therapy
3. Biology of cancer metastases
4. Preclinical studies of IL-2 activated natural killer effector cells for locoregional therapy of metastatic cancer
5. Establishment of cell-to-cell contact by adoptively transferred adherent lymphokine-activated killer cells with metastatic murine melanoma cells
6. Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
7. Tissue distribution of adoptively transferred adherent lymphokine-activated killer cells assessed by different cell labels
8. Localization of immune effector cells to tumor metastases
9. Ultrastructure of interactions between activated murine natural killer cells and melanoma cells in an extracellular matrix (Matrigel) environment
10. Perforin and granzymes: Crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity
11. Matrix metalloproteinases produced by rat IL-2 activated natural killer cells
12. Secreted and membrane-associated matrix metalloproteinases of IL-2 activated natural killer cells and their inhibitors
13. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor
14. Matrix metalloproteinases of human NK cells
15. Inhibition of matrix metalloproteinases
16. Matrix degrading metalloproteinases
17. Regulation of matrix metalloproteinase expression in tumor invasion
18. Matrix metalloproteinases
19. Human MT6-matrix metalloproteinase: Identification, progelatinase A activation, and expression in brain tumors
20. Processing of tumour necrosis factor-alpha precursor by metalloproteinases
21. Regulation of tumour necrosis factor- alpha processing by a metalloproteinase inhibitor
22. Metalloproteinase-mediated release of human Fas ligand
23. Proteolytic enzymes in cancer invasion and metastasis
24. Membrane-type matrix metalloproteinases (MT-MMPs) in cell invasion
25. Matrix metalloproteinases. Matrix degradation and more
26. Matrix metalloproteinases
27. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
28. Determination of tissue inhibitor of metalloproteinases-2 (TIMP-2) in experimental animals using monoclonal antibodies against TIMP-2-specific oligopeptides
29. A growth-responsive gene (16C8) in normal mouse fibroblasts homologous to a human collagenase inhibitor with erythroid-potentiating activity: Evidence for inducible and constitutive transcripts
30. Cell growth-promoting activity of tissue inhibitor of metalloproteinase-2 (TIMP-2)
31. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
32. K562 cells produced and respond to human erythroid-potentiating activity
33. Tissue inhibitor of metalloproteinases-1 (TIMP-1) RNA is expressed at elevated levels in malignant non-Hodgkin's lymphomas
34. Tax proteins of human T-cell leukemia virus type 1 and 2 induce expression of the gene encoding erythroid-potentiating activity (tissue inhibitor of metalloproteinases-1, TIMP-1)
35. Soy intake and cancer risk: A review of the in vitro and in vivo data
36. The role of soy products in reducing risk of cancer
37. Genistein inhibits proliferation similarly in estrogen receptor-positive and negative human breast carcinoma cell lines characterized by P21WAF1/CIP1 induction, G2/M arrest, and apoptosis
38. Biochemical targets of the isoflavone genistein in tumor cell lines
39. Evaluation of the biochemical targets of genistein in tumor cells
40. Genistein inhibits both constitutive and EGF- stimulated invasion in ER-negative human breast carcinoma cell lines
41. Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells
42. NKR-P1, a signal transduction molecule on natural killer cells
43. Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
44. Induction of metallo-proteinase activity in human T-lymphocytes
45. Basement membrane type IV collagen degradation: Evidence for the involvement of a proteolytic cascade independent of metalloproteinases
46. Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface
47. Regulation of membrane-type matrix metalloproteinase-1 expression by growth factors and phorbol 12-myristate 13-acetate
48. A matrix metalloproteinase expressed on the surface of invasive tumour cells
49. cDNA sequence and mRNA tissue distribution of a novel human matrix metalloproteinase with a potential transmembrane segment
50. Disulphide bond assignment in human tissue inhibitor of metalloproteinases (TIMP)
51. Interstitial collagenases
52. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction
53. Cellular mechanisms of human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme
54. Increased erythroid potentiating activity/tissue inhibitor of metalloproteinases and jun/fos transcription factor complex characterize tumor promoter-induced megakaryoblastic differentiation of K562 leukemia cells
55. Differentiation of a human leukemia cell line and expression of collagenase inhibitor